Vazkepa: ‘Constructive Discussions' Help Amarin Win Reimbursement For ‘Hundreds Of Thousands’ In UK
Reimbursement Discussions Progressing In Other European Markets
Amarin’s drug, which costs £144.21 for a 30-day supply, is to be made available on the National Health Service in England and Wales for reducing the risk of cardiovascular events after NICE reversed its previous rejection of the product.
